Abstract
“Business development” (BD) is an often used, but not well defined, term in the business world. Taking a strategy-as-practice perspective as a background, we explore the daily activities of BD in the German biotechnology industry. We show how BD tasks are defined and how they are fulfilled, what resources are used for this function and how it is organized. We compare our results with insights from the strategic management literature and show that business development is an example of what a modern type of planning might look like, but that it may be misleading to see the BD function in biotech firms in the same way as the dynamic capability the literature assumes. By doing this analysis, we contribute to an understanding of how entrepreneurial biotechnology ventures operate, and how they do their “strategizing” and “organizing” work.
Similar content being viewed by others
References
Amit, Raphael and Paul J.H. Schoemaker (1993), Strategic assets and organizational rent, Strategic Management Journal 14, 33–46.
Ansoff, H. Igor (1965), Corporate Strategy, New York: McGraw-Hill.
Arora, Andrea and Alfonso Gambardella (1990), Complementarity and external linkages: The strategies of large firms in biotechnology, Journal of Industrial Economics 38, 361–379.
A. T. Kearney (2000), Biotechnology in Berlin/Brandenburg: Goal: To Become a Leading Region in Europe, Berlin: A. T. Kearney.
Audretsch, David and Maryann P. Feldman (2003), Small-firm strategic research partnerships: the case of biotechnology, Technology Analysis & Strategic Management 15, 273–88.
Balogun, Julia, Anne S. Huff, and Phyl Johnson (2003), Three responses to the methodological challenges of studying strategizing, Journal of Management Studies 40, 197–224.
Baum, Joel A., Tony Calabrese, and Brian S. Silverman (2000), Don’t go alone: Alliance network composition and startups’ performance in Canadian biotechnology, Strategic Management Journal 21, 267–94.
Bourdieu, Pierre (1990), The Logic of Practice, Cambridge: Polity Press.
Bryman, Alan and Robert G. Burgess (1994), Analyzing Qualitative Data, New York: Routledge.
Burrill, Steven G. (2002), Biotech 2002, San Francisco: Burrill & Company.
Casper, Steven (2000), Institutional adaptiveness, technology policy, and the diffusion of new business models: The case of German biotechnology, Organization Studies 21, 887–914.
Champsi, Farah H. (1998), Biotechnology mergers and acquisitions, Nature Biotechnology 16, Supplement, 61–2.
Chandler, Alfred (1990), Scale and Scope: The Dynamics of Industrial Capitalism, Boston, MA: Harvard University Press.
Deeds, David L., Dona DeCarolis, and Joseph E. Coombs (1998), Firm-specific resources and wealth creation in high-technology ventures: Evidence from newly public biotechnology firms, Entrepreneurship Theory and Practice 22, 55–73.
Deeds, David L., Dona DeCarolis, and Joseph Coombs (1999), Dynamic capabilities and new product development in high technology ventures: An empirical analysis of new biotechnology firms, Journal of Business Venturing 15, 211–29.
Edelson, Steve and Mike Ward (2007), M&A upside, BioCentury 15, A1–A7.
Eisenhardt, Kathleen M. (1989), Building theories from case study research, Academy of Management Review 14, 532–50.
Eisenhardt, Kathleen M. (1991), Better stories and better constructs: The case for rigor and comparative logic, Academy of Management Review 16, 620–27.
Eisenhardt, Kathleen M. and Jeffrey A. Martin (2001), Dynamic capabilities: What are they?, Strategic Management Journal 21, 1105–21.
Ernst & Young (2000), Gründerzeit: Ernst & Young’s Zweiter Deutscher Biotechnologie Report 2000, Stuttgart: Ernst & Young.
Ernst & Young (2002), Neue Chancen — Deutscher Biotechnologie-Report 2002, Stuttgart: Ernst & Young.
Ernst & Young (2006), Beyond borders. Global biotechnology report 2006, New York: Ernst & Young.
Esposito, Robert S. and Marc J. Ostro (1998), Where have all the investors gone? The case for consolidation, Nature Biotechnology 6, Supplement, 63.
Ethiraj, Sendil K., Pranshant Kale, M. S. Krishnan, and Jitendra V. Singh (2005), Where do capabilities come from and how do they matter? A study in the software services industry, Strategic Management Journal 26, 25–45.
Foucault, Michel (1980), Power/Knowledge: Selected Interviews and Other Writings, 1972–1977, New York: Pantheon.
French, Michael J. (2002), Partnering challenges for startups, Nature Biotechnology 20, BE40–BE42.
Giddens, Anthony (1976), New Rules of Sociological Method, London: Hutchinson.
Gompers, Paul and Josh Lerner (2004), The Venture Capital Cycle, 2nd ed., Cambridge, MA: MIT Press.
Grant, Robert (1996), Prospering in dynamically-competitive environments: Organizational capability as knowledge integration, Organization Science 7, 375–387.
Henderson, Rebecca and Iain Cockburn (1994), Measuring competence? Exploring firm effects in pharmaceutical research, Strategic Management Journal 15, 63–84.
Henderson, Rebecca and Will Mitchell (1997), The interactions of organizational and competitive influences on strategy and performance, Strategic Management Journal 18, Summer Special Issue, 5–14.
Huygens, Marc, Charles Baden-Fuller, Frans A.J. van den Bosch, and Henk W. Volberda (2001), Co-evolution of firm capabilities and industry competition: Investigating the music industry, 1877–1997, Organization Studies 22, 971–1011.
Jarzabkowski, Paula (2003), Strategic practices: An activity theory perspective on continuity and change, Journal of Management Studies 40, 23–55.
Johnson, Gerry, Leif Melin, and Richard Whittington (2003), Guest editor’s introduction: Micro strategy and strategizing: Towards an activity-based view, Journal of Management Studies 40, 3–22.
Johnson, Gerry and Kevan Scholes (1999), Exploring Corporate Strategy, 5th ed., Essex: Prentice Hall.
Kale, Prashant, Jeffrey H. Dyer, and Harbir Singh (2002), Alliance capability, stock market response and long-term alliance success: The role of the alliance function, Strategic Management Journal 23, 747–67.
Langley, Anne (1999), Strategies for theorizing from process data, Academy of Management Review 24, 691–710.
Lerner, Josh and Robert P. Merges (1998), The control of technology alliances: An empirical analysis of the biotechnology industry, Journal of Industrial Economics 46, 125–56.
Lorange, Peter (1998a), Corporate Planning: An Executive Viewpoint, New York: Prentice-Hall.
Lorange, Peter (1998b), Strategy implementation: The new realities, Long Range Planning 31, 18–29.
MacIntyre, Alasdair (1985), After Virtue, 2d ed., London: Duckworth.
Madhok, Anoop and Thomas Osegowitsch (2000), The international biotechnology industry: A dynamic capability perspective, Journal of International Business Studies 31, 325–35.
Makadok, Richard (2001), Toward a synthesis of the resource-based and dynamic-capability views of rent creation, Strategic Management Journal 22, 387–401.
Miles, Matthew B. and A. Michael Huberman (1994), Qualitative Data Analysis: An Expanded Sourcebook, 2nd ed., London et al.: Sage.
Mintzberg, Henry (1973), The Nature of Managerial Work, New York: Harper and Row.
Mintzberg, Henry (1974), The manager’s job: Folklore and fact, Harvard Business Review 53(4), 49–62.
Mintzberg, Henry (1994), The Rise and Fall of Strategic Planning, Englewood Cliffs, NJ: Prentice Hall.
Mintzberg, Henry, Bruce Ahlstrand, and Joseph Lampel (2005), Strategy Bites Back: It Is Far More, and Less, Than You Ever Imagined, Upper Saddle River, NJ: Pearson Prentice Hall.
Moscho, Alexander, Regina A. Hodits, Friedemann Janus, and Josef M. Leiter (2000), Deals that make sense, Nature Biotechnology 18 (July), 719–22.
Papadoupolos, Stelios (1999), Biotechnology’s consolidation conundrum, Nature Biotechnology 17, Supplement, BE40–BE41.
Patzelt, Holger (2005), Bioentrepreneurship in Germany. Industry Development, M&As, Strategic Alliances, Crisis Management, and Venture Capital Financing, Dissertation, University of Bamberg.
Patzelt, Holger, Lars Schweizer, and Dodo zu Knyphausen-Aufseß (2005), Mergers and acquisitions of German biotechnology startups, International Journal of Biotechnology (forthcoming).
Persidis, Aris (1999), Consolidations in biotechnology, Nature Biotechnology 17, Supplement, BE3–BE4.
Pettigrew, Andrew (1990), Longitudinal field research on change: Theory and practice, Organization Science 1, 267–92.
Pisano, Gary P. (1994), Knowledge, integration and the locus of learning: An empirical analysis of process development, Strategic Management Journal 15, Winter Special Issue, 85–100.
Powell, Walter W. (1998), Learning from collaboration: Knowledge and networks in the biotechnology and pharmaceutical industries, California Management Review 40(3), 228–40.
Powell, Walter W., Kenneth W. Koput, and Laurel Smith-Doerr (1996), Interorganizational collaboration and the locus of innovation: Networks of learning in biotechnology, Administrative Science Quarterly 41, 116–45.
Powell, Walter W., Kenneth W. Koput, Laurel Smith-Doerr, and Jason Owen-Smith (1999), Network position and firm performance: Organizational returns to collaboration in the biotechnology industry, Research in the Sociology of Organizations 16, 129–59.
Rothaermel, Frank T. (2001a), Complementary assets, strategic alliances, and the incumbent’s advantage: An empirical study of industry and firm effects in the biopharmaceutical industry, Research Policy 30, 1235–51.
Rothaermel, Frank T. (2001b), Incumbent’s advantage through exploiting complementary assets via interfirm cooperation, Strategic Management Journal 22, 687–99.
Rothaermel, Frank T. and David L. Deeds (2004), Exploration and exploitation alliances in biotechnology: a system of new product development, Strategic Management Journal 25, 201–21.
Rothaermel, Frank T. and David L. Deeds (2006), Alliance type, alliance experience and alliance management capability in high-technology ventures, Journal of Business Venturing 21, 429–60.
Samra-Fredericks, Dalvir (2003), Strategizing as lived experience and strategists’ everyday efforts to shape strategic direction, Journal of Management Studies 40, 141–74.
Schweizer, Lars and Dodo zu Knyphausen-Aufseß (2006), Mergers and acquisitions in the biotechnology industry, in: Holger Patzelt, Thomas Brenner, and David B. Audretsch (eds.), Handbook of bioentrepreneurship, Kluwer/Springer: Dordrecht (forthcoming).
Taylor, Bernhard (1997), The return of strategic planning — once more with feeling, Long Range Planning 30, 334–44.
Teece, David (1980), Economy of scale and the scope of the enterprise, Journal of Economic Behavior and Organization 1, 223–45.
Teece, David J., Gary P. Pisano, and Amy Shuen (1997), Dynamic capabilities and strategic management, Strategic Management Journal 18, 509–33.
Turner, Stephen (1994), The Social Theory of Practices: Tradition, Tacit Knowledge and Presuppositions, Cambridge: Polity.
Van Brunt, Jennifer (2005), Biotech’s Old Soldiers, Signals Magazine, http://www.signalsmag.com/signalsmag.nsf/0/17004CFE1AE8BC5E88257091000C9367?Open.
Van Brunt, Jennifer (2006), M&As were hot in 2005, Signals Magazine, http://www.signalsmag.com/signalsmag.nsf/0/70187C6C350377088825712C007505B5.
VBU (2002), VBU Guide of German Biotech R&D Companies.
Wess, Ludger (2003), Breaking the spell in Germany?, BioCentury 17, 5–6.
Whittington, Richard (1996), Strategy as practice, Long Range Planning 29, 731–35.
Whittington, Richard (2002a), Corporate structure: From policy to practice, in Andrew Pettigrew, Howard Thomas and Richard Whittington (eds.), The Handbook of Strategy and Management, London: Sage Publications, 113–38.
Whittington, Richard (2002b), Seeing strategy as a social practice. Key Note Presentation.
Whittington, Richard (2003), The work of strategizing and organizing: for a practice perspective, Strategic Organization 1, 119–27.
Winter, Sydney G. (2003), Understanding dynamic capabilities, Strategic Management Journal 24, 991–95.
Yin, Robert K. (1994), Case Study Research: Design and Methods (2 ed.), London et al.: Sage Publications.
Zaby, Andreas (1999), Internationalization of High-technology Firms, Wiesbaden: Gabler.
Zu Knyphausen-Aufseß, Dodo, Andreas Zaby, and Sonja Kind (2006), M&A and diversification strategies of VC-backed firms in the biotechnology industry — toward understanding the perspectives of venture capitalists and their portfolio companies, in: John Butler (ed.), Venture Capital and Entrepreneurship, Information Age Publishing: Greenwich, CT, 199–221.
Author information
Authors and Affiliations
Corresponding author
Additional information
The alphabetical ordering of authorship reflects the fully collaborative nature of this work.
Rights and permissions
About this article
Cite this article
Kind, S., zu Knyphausen-Aufseß, D. What is “Business Development”? — The Case of Biotechnology. Schmalenbach Bus Rev 59, 176–199 (2007). https://doi.org/10.1007/BF03396747
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03396747